A considerable body of evidence suggests the involvement of serotonin neurotransmission in the pathogenesis of panic disorder. Research on pathways and functions of tryptophan, an essential amino acid converted into serotonin, may advance our understanding of serotonergic actions in panic disorder and related phenomena. The investigative approaches in this fi eld include manipulations of tryptophan availability as well as genetic association and functional brain imaging studies. In this review we examine the principle fi ndings of these studies and propose further research directions.Keywords: tryptophan, panic disorder, anxiety, challenge, gene Panic disorder (PD) is a prevalent and serious illness in need of a better understanding of its neurobiological basis to improve treatment outcomes. The pathogenesis, clinical manifestations and treatment effects of PD are thought to be substantially related to the functions of serotonin or 5-hydroxytryptamine (5-HT) neurotransmission. The crucial role of 5-HT in PD has been suggested by clinical studies demonstrating that medications specifi cally increasing the synaptic availability of 5-HT, especially the selective 5-HT re-uptake inhibitors (SSRIs), are particularly effective in the treatment of PD (Nutt, 1998). Extensive experience with SSRIs in the treatment of PD and the effect of tryptophan depletion (TD) to undermine this action underscored the necessity of increased synaptic availability of 5-HT for achieving remission. Furthermore, growing data from experimental and neuroimaging studies have suggested that altered availability of brain 5-HT is associated with PD; however the exact mechanisms of a possible disturbance in 5-HT metabolism are not fully understood . 5-HT is synthesized from the essential amino acid tryptophan via intermediate metabolite, 5-hydroxytryptophan (5-HTP), and stored in reserpine-sensitive vesicles until released into the synaptic cleft by nerve impulses. The conversion of tryptophan into 5-HTP is regulated by tryptophan hydroxylase (TPH), the rate limiting enzyme in biosynthesis of 5-HT. In the next step, 5-HTP is decarboxylated by aromatic acid decarboxylase to 5-HT. Unlike 5-HTP, tryptophan can be shunted into kynurenine via tryptophan 2,3-dioxygenase, making tryptophan unavailable for 5-HT production (Birdsall, 1998;Ruddick et al. 2006). TPH can be inhibited by numerous factors, including stress, insulin resistance, vitamin B6 deficiency, and insuffi cient magnesium, that may increase the conversion of tryptophan to kynurenine. Under normal conditions, the enzyme TPH is only about 50% saturated in brain, therefore the synthesis of 5-HT is dependent on the availability of free plasma tryptophan, whereas alterations in its availability correlate with the amount of synthesized 5-HT (Schaechter and Wurtman, 1990). Presently, the central 5-HT pathways remain the main targets in the research on the neurobiology of PD. In this paper we review the studies focusing on the role of tryptophan and discuss research directions in this are...